News & Analysis » India
Sun Pharma Gets USFDA Approval For Generic Strattera Capsules
(RTTNews) - Sun Pharmaceutical Industries Ltd. said it had obtained approval from USFDA for its Abbreviated New Drug Application or ANDA to market a generic version of Strattera hydrochloride capsules, with 180 days marketing exclusivity.
The company said these generic atomoxetine hydrochloride capsules are equivalent to Eli Lily's Strattera capsules, and include six strengths??10mg, 18 mg, 25mg, 40mg 60mg and 100mg.
Atomoxetine hydrochloride capsules are indicated for the management of attention deficit hyperactivity disorder in children aged six and older, teens and adults. Annual sales in the US for these strengths of branded and generic atomoxetine hydrochloride capsules is estimated at over $530 million, it added.
At the BSE, Sun Pharma shares are currently trading at Rs.1,746.30, down by 0.78% from the previous close.
Stock Market Forum
- Information about Stock trading - An Article
7 February 2012
- how do you find canada stocks to trade?
3 February 2012
- my stock to watch for tomorrow-CLD
3 February 2012
- Dynamic levels is all about showing the stock levels for last 12 years.
19 January 2012
- Bank of England Keeps Base Rate unaffected at 0.50%
13 January 2012
- Oil price rise fuels India's inflation
4 January 2012
- How to invest in stock market
27 December 2011
- Four Secrets to invest in Stock Market: Beginners Guide
27 December 2011
- Food inflation plunges to 4-year low of 1.81%
22 December 2011
- Nifty delete certain posts gains on GDP data
22 December 2011